Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.60
|
1.61
|
1.60
|
1.60
|
1.63
|
1.60
|
|
|
53 391.10
|
67.00
|
1.58
|
1.59
|
1.56
|
1.55
|
1.59
|
1.59
|
|
|
39 690.37
|
59.00
|
1.53
|
1.56
|
1.52
|
1.52
|
1.56
|
1.54
|
|
|
107 892.75
|
98.00
|
1.52
|
1.53
|
1.54
|
1.50
|
1.54
|
1.53
|
|
|
16 888.04
|
37.00
|
1.50
|
1.52
|
1.50
|
1.49
|
1.53
|
1.50
|
|
|
47 251.99
|
71.00
|
1.47
|
1.49
|
1.48
|
1.45
|
1.49
|
1.47
|
|
|
21 549.10
|
42.00
|
1.47
|
1.53
|
1.44
|
1.43
|
1.55
|
1.49
|
|
|
91 533.09
|
125.00
|
1.44
|
1.47
|
1.49
|
1.41
|
1.49
|
1.47
|
|
|
42 511.09
|
55.00
|
1.43
|
1.45
|
1.46
|
1.43
|
1.46
|
1.43
|
|
|
33 156.48
|
67.00
|
1.43
|
1.50
|
1.42
|
1.42
|
1.48
|
1.46
|
|
|
50 442.31
|
110.00
|
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer.